ICON PLC

More Details of ICON PLC Company

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Company Info

Ticker SymbolICLR

Company nameICON PLC

IPO dateMay 15, 1998

Founded at1989

CEODr. Stephen (Steve) Cutler, Ph.D.

Number of employees41900

Security typeOrdinary Share

Fiscal year-endMay 15

AddressSouth County Business Park

CityDUBLIN

Stock exchangeNASDAQ Global Select Consolidated

CountryIreland

Postal code- -

Phone35312912000

Websitehttps://www.iconplc.com/

Ticker SymbolICLR

IPO dateMay 15, 1998

Founded at1989

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+3.40%

Dr. Linda S. Grais, M.D., J.D.

Independent Director

4.91K

+10.73%

Ms. Julie O'Neill

Independent Director

2.37K

+22.58%

Mr. Eugene Mccague

Independent Director

2.12K

+26.25%

Dr. John Climax

Independent Director

--

Mr. Nigel Clerkin

Chief Financial Officer

--

Mr. Barry Edward Balfe

Chief Operating Officer

--

Ms. Anne C. Whitaker

Independent Director

--

Dr. Stephen (Steve) Cutler, Ph.D.

Chief Executive Officer, Director

--

Mr. Ronan Murphy

Lead Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+3.40%

Dr. Linda S. Grais, M.D., J.D.

Independent Director

4.91K

+10.73%

Ms. Julie O'Neill

Independent Director

2.37K

+22.58%

Mr. Eugene Mccague

Independent Director

2.12K

+26.25%

Dr. John Climax

Independent Director

--

Mr. Nigel Clerkin

Chief Financial Officer

--

Revenue Breakdown

Currency: USDUpdated: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

No Data

By RegionUSD

Name

Revenue

Proportion

United States

2.99B

36.05%

Ireland

2.79B

33.73%

Rest of Europe

1.56B

18.85%

Rest of the World

942.64M

11.38%

By Business

By Region

No Data

Shareholding Stats

Updated: Sat, May 17

Shareholders

Shareholder Types

Shareholders

Proportion

WCM Investment Management

8.04%

Artisan Partners Limited Partnership

5.40%

Wellington Management Company, LLP

4.65%

Ninety One UK Limited

3.67%

MFS Investment Management

3.56%

Other

74.68%

Shareholders

Proportion

WCM Investment Management

8.04%

Artisan Partners Limited Partnership

5.40%

Wellington Management Company, LLP

4.65%

Ninety One UK Limited

3.67%

MFS Investment Management

3.56%

Other

74.68%

Shareholder Types

Shareholders

Proportion

Investment Advisor

42.83%

Investment Advisor/Hedge Fund

41.96%

Hedge Fund

8.63%

Research Firm

2.38%

Pension Fund

2.30%

Bank and Trust

1.43%

Sovereign Wealth Fund

1.27%

Family Office

1.09%

Family Office

1.09%

Institutional Shareholding

Updated: Mon, Jan 20

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q1

1335

78.86M

99.22%

-6.92M

2024Q4

1334

80.88M

97.97%

-5.29M

2024Q3

1290

83.28M

100.86%

-2.02M

2024Q2

1273

83.12M

100.37%

-2.47M

2024Q1

1254

83.08M

100.49%

-3.81M

2023Q4

1237

84.94M

102.98%

-3.00M

2023Q3

1213

86.31M

104.85%

-1.65M

2023Q2

1199

85.95M

104.64%

+2.46M

2023Q1

1190

81.67M

99.73%

-2.49M

2022Q4

1181

81.26M

99.51%

-4.28M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

WCM Investment Management

6.33M

7.67%

-319.37K

-4.80%

Dec 31, 2024

Wellington Management Company, LLP

2.11M

2.56%

-968.73K

-31.43%

Dec 31, 2024

Ninety One UK Limited

2.95M

3.57%

+250.55K

+9.29%

Dec 31, 2024

MFS Investment Management

2.89M

3.5%

-868.59K

-23.12%

Dec 31, 2024

Invesco Advisers, Inc.

1.38M

1.67%

-38.13K

-2.69%

Dec 31, 2024

AllianceBernstein L.P.

1.82M

2.21%

+502.55K

+38.10%

Dec 31, 2024

ClearBridge Investments, LLC

2.05M

2.49%

+555.48K

+37.12%

Dec 31, 2024

Templeton Investment Counsel, L.L.C.

1.88M

2.28%

+694.07K

+58.34%

Dec 31, 2024

D. E. Shaw & Co., L.P.

1.12M

1.35%

+950.74K

+574.59%

Dec 31, 2024

Related ETFs

Updated: Fri, Jun 6

Name

Proportion

Polen Capital International Growth ETF

4.98%

iShares MSCI Ireland ETF

4.72%

VanEck Biotech ETF

2.72%

Polen Capital Global Growth ETF

2.5%

Harbor Health Care ETF

2.27%

Janus Henderson US Sustainable Equity ETF

1.58%

Running Oak Efficient Growth ETF

1.5%

Motley Fool Global Opportunities ETF

1.22%

FPA Global Equity ETF

1.15%

Brandes US Value ETF

1.05%

Polen Capital International Growth ETF

Proportion4.98%

iShares MSCI Ireland ETF

Proportion4.72%

VanEck Biotech ETF

Proportion2.72%

Polen Capital Global Growth ETF

Proportion2.5%

Harbor Health Care ETF

Proportion2.27%

Janus Henderson US Sustainable Equity ETF

Proportion1.58%

Running Oak Efficient Growth ETF

Proportion1.5%

Motley Fool Global Opportunities ETF

Proportion1.22%

FPA Global Equity ETF

Proportion1.15%

Brandes US Value ETF

Proportion1.05%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

145.660USD

ICON PLC

145.660

Overview

Company